share_log

Obalon Therapeutics | 10-K: FY2018 Annual Report

SEC ·  Feb 22, 2019 21:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more